Page last updated: 2024-09-03
l 649923 and vapiprost
l 649923 has been researched along with vapiprost in 1 studies
Compound Research Comparison
| Studies (l 649923) | Trials (l 649923) | Recent Studies (post-2010) (l 649923) | Studies (vapiprost) | Trials (vapiprost) | Recent Studies (post-2010) (vapiprost) |
|---|---|---|---|---|---|
| 36 | 4 | 0 | 129 | 17 | 2 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Abbate, M; Gaspari, F; Pasini, M; Perico, N; Remuzzi, G | 1 |
Other Studies
1 other study(ies) available for l 649923 and vapiprost
| Article | Year |
|---|---|
Co-participation of thromboxane A2 and leukotriene C4 and D4 in mediating cyclosporine-induced acute renal failure.
Topics: Acute Kidney Injury; Analysis of Variance; Animals; Biphenyl Compounds; Blood Pressure; Cyclosporine; Drug Antagonism; Glomerular Filtration Rate; Heptanoic Acids; Injections, Intravenous; Kidney; Male; Metabolic Clearance Rate; Phenylbutyrates; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Thromboxane; SRS-A; Thromboxane A2 | 1991 |